|
| Figure 2: Time to discontinuation of initial antiretroviral therapy. By log-rank analysis, no significant difference in tim e to discontinuation of the initial regimen was observed for patients discontinuing an NNRTI-based regimen (n=106) or a ritonavir-boosted PI-based regimen (n=57). |
